Small hepatocellular carcinoma: Past, present and future

Chinese Medical Journal

Volumn 109, Issue 1, 1996, Pages 21-24

  Tang, Zhaoyou ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MORTALITY; REVIEW; SURVIVAL RATE;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; SURVIVAL RATE;

EID: 0029678922     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. Cancer J Clin 1995; 45:8.
2. Ikeda K, Saitoh S, Koida I, et al. Imaging diagnosis of small hepatocellular carcinoma. Hepatology 1994; 20:82.
3. Zhou XD, Tang ZY, Yu YQ, et al. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases. J Cancer Res Clin Oncol 1993; 120:100.
4. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer 1992; 69:925.
5. Okuda K. Intratumor ethanol injection. J Surg Oncol 1993; 3:97s.
6. Kuroda C, Sakurai M, Monden M, et al. Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma. Cancer 1991; 67:881.
7. Tang ZY, Yu YQ, Zhou XD. An important approach to prolonging survival further after radical resection of AFP positive hepatocellular carcinoma. J Exp Clin Cancer Res 1984; 3:359.
8. Nakajima Y, Ohmura T, Kimura J, et al. Role of surgical treatment for recurrent hepatocellular carcinoma after hepatic resection. World J Surg 1992; 17:792.
9. Wu MC, Chen H, Yan YQ. Rehepatectomy of primary liver cancer. Semin Surg Oncol 1993; 9:323.
10. Esumi M, Aritaka T, Arii M, et al. Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res 1986; 46:5767.
11. Chen PJ, Chen DS, Lai MY, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology 1989; 96:527.
12. Liang XH, Loncarevic IF, Tang ZY, et al. Resection of hepatocellular carcinoma: oligocentric origin of recurrent and multinodular tumors. J Gastroenterol Hepatol 1991; 6:77.
13. Tang ZY, Yu YQ, Zhou XD. Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s. Semin Surg Oncol 1993; 9:293.
14. Makuuchi M, Kosuge T, Takayama T, et al. Surgery of small liver cancers. Semin Surg Oncol 1993; 9:298.
15. Tang ZY, Ying YY, Guo TJ. Hepatocellular carcinoma: cha nging concepts in recent years. In: Popper H, Schaffner F, eds. Progress in liver diseases. New York, Grune & Stratton, 1982:637-47.
16. Tang ZY, ed. Subclinical hepatocellular carcinoma. Beijing: China Acad Publ: Berlin: Springer-Verlag, 1985:1-366.
17. Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74:817.
18. Tang ZY, Yu YQ, Zhou XD, et al. Treatment of unresectable primary liver cancer: with reference to cytoreduction and sequential resection. World J Surg 1995; 19:47.
19. Bismuth H, Chiche L. Comparison of hepatic resection and transplantation in the treatment of liver cancer. Semin Surg Oncol 1993; 9:341.
20. Iwatsuki S, Starzl TE. Role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol 1993; 9:337.
21. Chen MF, Hwang TL, Jeng LB, et al. Postoperative recurrence of hepatocellular carcinoma-two hundred and five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994; 129:738.
22. Arii S, Tanaka J, Fujita K, et al. A retrospective study of the preventive effect of transarterial chemotherapy for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. J Hep Bil Pancr Surg 1994; 1:263.
23. Okada S, Ishii H, Nose H, et al. Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer 1995; 75:444.
24. Okada S, Okazaki N, Nose H, et al. Prognostic significance of flow cytometric DNA analysis in hepatocellular carcinoma: a prospective study of 124 patients. Int Hepatol Comm 1993; 1:109.
25. Ng IOL, Lai ECS, Fan ST, et al. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994; 73:2268.
26. Matsumura M, Niwa Y, Kato N, et al. Detection of alpha-fetoprotein mRNA, an indication of hematogenous spreading hepatocellular carcinoma in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20:1418.
27. Tabor E. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 1994; 42:357.
28. Hsu HC, Tseng HJ, Lai PL, et al. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res 1993; 53:4691.
29. Boix L, Bruix J, Campo E, et al. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology 1994; 107:486.
30. Fan Z, Masui H, Altas I, et al. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 1993; 53:4322.
31. Laird AD, Brown PI, Fausto N. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor antisense gene. Cancer Res 1994; 54:4224